Top 50 Biotechnology VC Funds & Investors in Sweden (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Chalmers Ventures AB
VC Fund
|
26 | Sweden | Pre-Seed, Seed | Software, Biotechnology, Information Technology | $5.8k–$2.3M |
|
Industrifonden
VC Fund
|
17 | Sweden, United States, Denmark | Series A, Seed | Biotechnology, Software, Information Technology | $1.2M–$21M |
|
Almi Invest
VC Fund
|
17 | Sweden, United States, Ukraine | Seed, Venture - Series Unknown | Software, Health Care, Information Technology | $230k–$5M |
|
Sciety
VC Fund
|
14 | Sweden, Ukraine | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Medical | $128k–$6.9M |
|
Navigare Ventures
VC Fund
|
8 | Sweden, Denmark | Seed, Series A, Venture - Series Unknown | Biotechnology, Energy, Manufacturing | $470k–$21M |
|
Novo Holdings
VC Fund
|
6 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.9M–$135M |
|
HealthCap
VC Fund
|
5 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$92M |
|
Karolinska
VC Fund
|
4 | Sweden, Denmark, United States | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $1.3M–$73M |
|
Norrsken VC
VC Fund
|
4 | Sweden, United Kingdom, Germany | Seed, Series A | Software, Food and Beverage, Artificial Intelligence | $700k–$56M |
|
BackingMinds
VC Fund
|
3 | Sweden, Denmark, Finland | Seed, Pre-Seed | Software, SaaS, Energy | $826k–$8.2M |
|
I Love Lund
VC Fund
|
3 | Sweden | Venture - Series Unknown, Pre-Seed, Seed | Biotechnology, Medical, Forestry | $38k–$2.2M |
|
Inventure
VC Fund
|
3 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$25M |
|
Partnerinvest Norr
VC Fund
|
3 | Sweden, United States | Seed, Venture - Series Unknown | Software, Manufacturing, Information Technology | $588k–$6.1M |
|
Fåhraeus Startup and Growth
VC Fund
|
3 | Sweden, Denmark, Finland | Seed, Venture - Series Unknown, Series A | Medical, Health Care, Biotechnology | $851k–$7.3M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
Voima Ventures
VC Fund
|
3 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $464k–$30M |
|
EIR Ventures
VC Fund
|
3 | Denmark, Sweden, United States | Series A, Seed | Biotechnology, Health Care, Therapeutics | $20M–$73M |
|
Crowberry Capital
VC Fund
|
3 | Iceland, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Health Care | $400k–$17M |
|
Noaber
VC Fund
|
2 | The Netherlands, Israel, Germany | Seed, Series A | Health Care, Medical, Fitness | $423k–$20M |
|
Life Science Invest
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Medical, Biotechnology, Biopharma | $310k–$4.6M |
|
Bånt AB
VC Fund
|
2 | Sweden | Seed | Biotechnology, Manufacturing, Food Processing | |
|
Länsförsäkringar
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Real Estate, Biotechnology, Manufacturing | $484k–$1.3M |
|
Nina Capital
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
|
Colibri Ventures
VC Fund
|
2 | Sweden, Mexico | Seed, Series A, Venture - Series Unknown | Gaming, Finance, Wellness | $6M–$6M |
|
FBG Invest
VC Fund
|
2 | Sweden | Seed | Biotechnology, Manufacturing, Food Processing | |
|
Nordic Science Investments
VC Fund
|
2 | Finland, Sweden, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$4.6M |
|
Hadean Ventures
VC Fund
|
2 | Norway, Sweden, Austria | Series A, Series B | Biotechnology, Health Care, Medical | $4.3M–$79M |
|
LU Holding
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Biotechnology, Software, Medical Device | |
|
ARCH Venture Partners
VC Fund
|
2 | United States, China, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $10M–$250M |
|
Flerie Invest
VC Fund
|
2 | Sweden, United States, United Kingdom | Series A, Venture - Series Unknown, Series B | Biotechnology, Health Care, Pharmaceutical | $2.5M–$75M |
|
LIU Invest
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Biotechnology, Information Technology, AgTech | $88k–$1.4M |
|
Faro Capital
VC Fund
|
2 | Sweden, United States | Series A, Seed, Venture - Series Unknown | Biotechnology, Gaming, Medical | $2.8M–$25M |
|
Segulah Medical Acceleration
VC Fund
|
2 | Sweden, United Kingdom, Germany | Series D, Series A, Series B | Health Care, Medical Device, Medical | $8.5M–$245M |
|
SEB Venture Capital
VC Fund
|
2 | Sweden, Denmark, United Kingdom | Series A, Series B | Software, Information Technology, FinTech | $1.2M–$23M |
|
Inven2
VC Fund
|
1 | Sweden | Series A | Therapeutics, Biotechnology, Pharmaceutical | |
|
Social Starts
VC Fund
|
1 | United States, Germany, United Kingdom | Seed, Series A | Software, Health Care, Artificial Intelligence | |
|
Impilo
VC Fund
|
1 | Sweden, Denmark | Biotechnology, Pharmaceutical, Medical | ||
|
Monesi
VC Fund
|
1 | Sweden | Pre-Seed | Life Science, Biotechnology | |
|
HJKK Didrikson
VC Fund
|
1 | Sweden | Seed | Biopharma, Biotechnology, Pharmaceutical | |
|
Phase2Phase Biopharma
VC Fund
|
1 | Sweden | Seed | Biopharma, Biotechnology, Pharmaceutical | |
|
Inter Ikea
VC Fund
|
1 | Germany, Sweden, Denmark | Seed, Corporate Round | Software, Furniture, Health Care | |
|
Ackra Invest
VC Fund
|
1 | Sweden | Seed | Manufacturing, Mining, Chemical | |
|
CBC Investment Group
VC Fund
|
1 | Sweden, Denmark, Germany | Seed, Series B | Software, Biotechnology, SaaS | |
|
Leksell Social Ventures
VC Fund
|
1 | Sweden, United States | Seed, Series B | Health Care, Apps, Fitness | |
|
Almi Invest GreenTech
VC Fund
|
1 | Sweden | Seed, Series A | Waste Management, Energy, Manufacturing | |
|
Nxt2b
VC Fund
|
1 | Sweden | Series A | Health Care, Biotechnology, Health Diagnostics | |
|
KTH Holding
VC Fund
|
1 | Sweden | Seed, Pre-Seed | Software, Information Technology, Biotechnology | |
|
Nordic Foodtech VC
VC Fund
|
1 | Finland, Sweden, Denmark | Seed, Series A | Biotechnology, Life Science, Water | |
|
Knutsson Holdings AB
VC Fund
|
1 | Sweden, Germany | Series C | Gaming, Billing, Parking | |
|
Kale United
VC Fund
|
1 | Sweden, United Kingdom, Canada | Seed, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $100k–$2.5M |
| Access all 300 VC funds in Sweden Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Pre-Seed, Seed
- Geography: Sweden
Investor stats
- Total investments: 249
- Round size: Seed $285k–$2.3M; Pre-Seed $5.8k–$318k
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Anferra — Turning hazardous steel waste into clean water and green energy.
- InfiniNode Technologies AB — InfiniNode is a semiconductor IP company that seeks to enable efficient data movement in future compute systems.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Biotechnology, Software, Information Technology
- Stage:Series A, Seed
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 197
- Round size: Seed $1.2M–$6.2M; Series A $3.3M–$21M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Yangi — Yangi is a provider of environmentally friendly packaging solutions.
- Fyndiq — Fyndiq is an e-commerce platform through which we offer a range of products for bargain hungry shoppers. We provide a sales channel for all types of e-tailers who want to boost their sales in an accessible way. Through Fyndiq individual retailers can effect fully sell of its overstock, while consumers have a one stop shop for bargain productsonline. Fyndiq offers more then 220 000 products to consumers from over 1 100 merchants in Sweden. Fyndiq was founded in Stockholm in August 2009 and launched its platform in august 2010. Since then we have been growing rapidly both in terms of turnover and employees. In 2012 our sales was 56 million SEK, a number we doubled in 2013 to sales of almost 124million SEK. In November 2014 Fyndiq raises $20M to take the platform internationally. The funding is notable in that it was led by one of the more prominent VCs based in the Nordics, Northzone, which was an early investor in Spotify. The other investor in this round, Industrifonden, is a VC backed by the Swedish government that invests in startups from the country to help scale them internationally. Currently we are 75 dedicated and motivated team members who make it all happen.
- Avtal24 — Avtal24 offers in an easily accessible manner agreements for both private individuals and companies. They believe in making the law available to everyone and they want everyone to have access to legal security. With us, you write agreements online or together with a lawyer by phone. Always at a fixed price. With high legal expertise, innovativetechnology and great focus on customer benefit and offer the market's most accessible legal services.Avtal24 was founded in 2004 and is headquartered in Stockholm, Sweden.
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States, Ukraine
Investor stats
- Total investments: 339
- Round size: Seed $230k–$2.3M; Venture - Series Unknown $561k–$5M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- FirstQFM — FirstQFM is a Stockholm-based quantum technology company building proprietary foundation models for quantum computing.
- Brighteco — Brighteco is an innovative and value-driven Born Circular startup that offers Light as a Service. All Brighteco hardware are build modular and circular from e.g reused computer screens.
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, Ukraine
Investor stats
- Total investments: 46
- Round size: Seed $128k–$2.3M; Series A $439k–$6.5M; Venture - Series Unknown $1.6M–$6.9M
- Lead/follow: 93% lead, 7% follow
Portfolio highlights
- Capitainer — Capitainer enables patients to collect their own volume-defined dried blood spot at home.Capitainer started in 2016. Their technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitaineroffers impressive cost and environmental savings for healthcare providers managing millions of conventional blood samples annually.
- Everdrone — Advanced drone operations for public safety and emergency response
- Single Technologies — SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 370
- Round size: Series A $9.9M–$133M; Series B $12M–$135M; Series C $30M–$118M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Tarveda Therapeutics — Developing Pentarins to make a difference in the treatment of patients with solid tumor malignancies
- Tarsa Therapeutics — Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that slows the rate of bone destruction.
- Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 133
- Round size: Series A $5.7M–$85M; Series B $12M–$92M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 32
- Round size: Series A $1.3M–$73M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
- Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more...Investment focus
- Industry: Software, Food and Beverage, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Sweden, United Kingdom, Germany
Investor stats
- Total investments: 108
- Round size: Seed $700k–$14M; Series A $4.2M–$56M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $340M in 2024
Portfolio highlights
- Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
- Verse — Define & achieve your financial and emissions reduction goals with Aria, a software platform that helps companies buy and manage clean power.
- Endra — Endra is a purpose-built platform for modern MEP engineering. Generate 3D models and drawings, sync with Revit and enjoy coordinated design workflows.
We help great minds unleash their full potential!
Show more...Investment focus
- Industry: Software, SaaS, Energy
- Stage:Seed, Pre-Seed
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 35
- Round size: Seed $854k–$3.7M; Pre-Seed $826k–$8.2M
- Lead/follow: 63% lead, 37% follow
- Last fund: Likely still investing — raised $53M in 2022
Portfolio highlights
- Tavion — Critical energy storage infrastructure for a sustainable future.
- Cetasol — Cetasol provides maritime monitoring and analytics software for commercial vessel fleets. Reduce fuel costs, optimize performance, and support regulatory compliance and emissions reporting.
- Helios Innovations — Helios Innovations offers modular evaporation that treats industrial process water on-site. Pay per cubic meter treated. No investment, no complexity.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!I Love Lund is a venture capital firm.The firm seeks opportunities to invest in pre-seed rounds
Show more...Investment focus
- Industry: Biotechnology, Medical, Forestry
- Stage:Venture - Series Unknown, Pre-Seed, Seed
- Geography: Sweden
Investor stats
- Total investments: 7
- Round size: Pre-Seed $420k–$456k; Venture - Series Unknown $38k–$2.2M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Cyclicor — Cyclicor is an innovations based company focused on the development and commercialisation of safer and more sustainable polymers. The company was registered in October of 2012 as a spin-off company from the University of Lund in Sweden and began commercial development of its first product Cycli-ClearTM, a bisphenol free polycarbonate, in late 2013.
- Katam Technologies — Katam Technologies helps forestry companies all over the world optimize operations through digitalization, solid data, and planning. With the aid of digitalization, reliable data, and careful planning, Katam assists forestry companies all over the world in maximizing operations. Small businesses and private forest owners can use the Katam app orKatam portal as standalone products to obtain quick and precise measurements.
- Valkyr Defense Systems — Valkyr specializes in cost-effective, modular, and autonomous defense systems, leveraging commercial off-the-shelf (COTS) technology to fast-track production.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 176
- Round size: Seed $549k–$5.9M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Leetify — We help gamers identify their weaknesses, work on those weaknesses and track their progression.
- UpCloud — World's fastest cloud servers with a 100% uptime SLA! Sign up for a free trial today.
- ONEiO — ONEiO is a cloud-native integration service provider connecting people, processes, and tools – enabling seamless collaboration without traditional integration hassle. Provided as a turn-key solution, as self-service, or something in between. You choose.
Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors. Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 69
- Round size: Seed $588k–$2.1M; Venture - Series Unknown $794k–$6.1M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- Cold River Games — Crystalfall is an upcoming free online action RPG with customizable skills and an endless endgame, set in a steampunk world.
- Original Creation — Original Creation envisions a sustainable future in which capital is focused on long-term benefits for both people and the environment, and resources are properly managed through circular systems."
- Remos Space Systems — Remos Space Systems simplifies satellite ground operations.
Fåhraeus Startup and Growth is a venture capital fund that invests early in life science and tech companies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 14
- Round size: Seed $851k–$2.7M; Series A $1.8M–$5.9M; Venture - Series Unknown $1.1M–$7.3M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
- Fida Biosystems — Quantification and characterisation of complex biology made simple. Study molecular interactions in solution, with only nanoliters of sample. Used by industry leaders.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 104
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 60
- Round size: Seed $1M–$5.9M; Pre-Seed $464k–$2.1M; Series A $3.9M–$30M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Sofi Filtration — Innovation in Industrial Liquid Filtration
EIR Ventures is a new Life Science Venture Group in the Nordics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Seed
- Geography: Denmark, Sweden, United States
Investor stats
- Total investments: 13
- Round size: Series A $20M–$73M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $143M in 2021
Portfolio highlights
- ArgusEye — ArgusEye is a biotechnology company that provides sensor solutions for real-time detection of biological systems and processes. ArgusEye's patented sensor technology is the result of extensive academic research and is based on nanoplasmonic sensing with fiber optics. By adding customized receptors, ArgusEye can offer flexible and sensitivesensing systems for a variety of targets.
- Moleculent — Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in biological research.
- Hoba Therapeutics — Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more...Investment focus
- Industry: Software, Gaming, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Iceland, Denmark, Finland
Investor stats
- Total investments: 50
- Round size: Seed $1.6M–$4.4M; Pre-Seed $400k–$1.3M; Series A $5.7M–$17M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
- Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
- Augmented Hearing — Read more about danish audiology scale-up Augmented Hearing, driving the world's most ambitious audiology solutions and innovations.
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more...Investment focus
- Industry: Health Care, Medical, Fitness
- Stage:Seed, Series A
- Geography: The Netherlands, Israel, Germany
Investor stats
- Total investments: 20
- Round size: Seed $423k–$6.3M; Series A $3M–$20M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
- Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
LSI Academy - New education 2026, read more here
Show more...Investment focus
- Industry: Medical, Biotechnology, Biopharma
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Seed $682k–$4.6M; Pre-Seed $310k–$500k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Haga Bioscience — Mission Technology Assays Benefits Team Contact us Focus whereit truly matters. In situ RNA detection at single nucleotide resolution, bridging discovery and translation. Our mission Bridging discovery and translation Spatial omics technologies have transformed how we study tissue biology.However, translating these discoveries into robust, actionable biomarkers remains a major bottleneck, limited by a lack of
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Bånt AB
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food Processing
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
Länsförsäkringar is a Swedish group of public insurance companies.
Show more...Investment focus
- Industry: Real Estate, Biotechnology, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 12
- Round size: Seed $484k–$1.3M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Stendorren Fastigheter — Stendorren Fastigheter is a company involved in the real estate industry. It develops, owns, operates, and maintains industrial, logistical, and warehouse facilities. The business offers adequate and suitable space on fair lease terms through its tenant.
- pixlbio (formerly Phenaros) — Data-centric drug discovery with AI, Phenomics and Automation.
- Swedish Logistic Property — Swedish Logistic Property (SLP) specializes in the development and management of logistics properties across Sweden. With a focus on energy efficiency, SLP provides modern logistics solutions tailored to meet the needs of various businesses. The company's portfolio includes strategically located properties designed to support efficientlogistics and supply chain operations. SLP also engages in the acquisition and development of new properties, aiming to expand its footprint in the logistics real estate market. The company's commitment to sustainability is evident in its construction practices and the operation of its logistics facilities.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 95
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and outcomes.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Colibri Ventures invest in early-stage life science companies and help accelerate their innovations into commercial products.
Show more...Investment focus
- Industry: Gaming, Finance, Wellness
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, Mexico
Investor stats
- Total investments: 4
- Round size: Seed $6M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mundi — Mundi provides financial, trade development, strategy, freight and reinventing international trade services.
- Mindforce Game Lab — Mindforce Game Lab creates meaningful games with characters that act as companions on the journey to better health.
- Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.
FBG Invest
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food Processing
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 17
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.9M
- Lead/follow: 88% lead, 12% follow
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- mu-ray.tech — Mu-ray.tech is focused on advancing the field of medical diagnostics and industrial quality control. mu-ray.tech is developing a groundbreaking technology for the rapid, safe and accurate 3D-imaging of the chemical composition of scanned objects, serving critical needs in industrial quality control and medical diagnostics. The technology is basedon Muon Beam Imaging (MBI), an innovative technology leveraging Laser Plasma Accelerator-based artificial muon sources, new generation particle detector systems and AI. In industry, we are working with the partners in the heavy, aerospace, and defence domains.mu-ray.tech operates at the three sites: DESY in Hamburg (hardware), Tehnopol in Tallinn (algorithms and software), and Bradfield Centre in Cambridge (algorithms, business development). Our main collaboration on the MBI technology partners are GScan in Estonia and UK, DESY in Hamburg, the University of Cambridge, and KBFI in Tallinn.
- Perfat Technologies — Perfect fats for better foods.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Norway, Sweden, Austria
Investor stats
- Total investments: 32
- Round size: Series A $4.3M–$79M; Series B $4.5M–$75M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $105M in 2021
Portfolio highlights
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
LU Holding is a Lund University’s investment company.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- MedVasc — MedVasc has developed Solution a patented medical device that reduces pain when treating varicose veins.
- Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 432
- Round size: Series A $10M–$216M; Series B $14M–$250M; Series C $15M–$167M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Synchron — The endovascular brain computer interface.
- Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
- LifeMine Therapeutics — LifeMine is a clinical-stage biopharmaceutical company pioneering a bold new approach, Top-Down Drug DiscoveryTM, which leverages evolutionary insights from fungi to unearth next-generation precision medicines.
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Sweden, United States, United Kingdom
Investor stats
- Total investments: 24
- Round size: Series A $2.5M–$23M; Series B $12M–$75M; Venture - Series Unknown $4.5M–$47M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!LIU invests in companies that are based on projects and ideas from Linköping University. LIU Invest is focused on investments in early phases. Investments are typically 250 000, but can be doubled by an additional investment.
Show more...Investment focus
- Industry: Biotechnology, Information Technology, AgTech
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 9
- Round size: Seed $579k–$1.4M; Pre-Seed $88k–$282k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.
- Sonicflora — Plants have always been speaking. We can now understand them.
- Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally.Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection tobecome the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term.Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.
Show more...Investment focus
- Industry: Biotechnology, Gaming, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 5
- Round size: Series A $2.8M–$25M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
- Bluwhale — Unlock Web3 Wallet Potential with AI Insights. Supercharge Your Business Growth
- IntuiCell — IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A, Series B
- Geography: Sweden, United Kingdom, Germany
Investor stats
- Total investments: 7
- Round size: Series A $8.5M–$12M; Series D $34M–$245M
- Lead/follow: 71% lead, 29% follow
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
- Collective Minds — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Series A, Series B
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 72
- Round size: Series A $1.2M–$12M; Series B $2.2M–$23M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $300M in 1995
Portfolio highlights
- Apica — Apica is the agentic-ready telemetry pipeline that cuts observability costs up to 40%. Control your data, eliminate tool sprawl, and scale for AI.
- MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
- CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
Inven2 specializes in the commercialization of research and to make outstanding research into the industry of the future.
Show more...Investment focus
- Industry: Therapeutics, Biotechnology, Pharmaceutical
- Stage:Series A
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 288
- Lead/follow: no public data
Portfolio highlights
- Hey Jane — Get safe, effective and affordable abortion pills delivered fast to your home. Hey Jane is the first digital abortion clinic, connecting you to licensed providers in your state through telemedicine.
- Mae Health — Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.
- Wayfinder Biosciences — We design RNA for next generation biomanufacturing and smart therapeutics.
Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Its starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which theyoperate in order to remain successful in the long term. It was founded in 2017 and is based in 2017 and is based in Stockholm, Sweden.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Medical
- Geography: Sweden, Denmark
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Cavidi — Cavidi is Sweden’s leading supplier of viral load for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can live a normal lifespan. Cavidi’s diagnostics reduce the cost of treatment and the spread of HIV. Cavidi also provides tools and kits for virus research to many of theworld’s leading labs.Cavidi is a Swedish biotech company founded as a spin-off from Uppsala University. Their expertise is based on understanding viruses and using this knowledge to create research tools and clinical diagnostics. Today their focus is on HIV but our methods and expertise can be applied to other viruses.Cavidi’s head office is in Uppsala, Sweden and they have sales offices in South Africa, India and USA. Their customers include hospitals, patient clinics, private laboratories, the pharmaceutical industry and research institutions worldwide.
- Scantox — Since 1977 Scantox has been a trusted partner for in-vivo preclinical research services for the pharmaceutical and medical device industries.
- Pelago Bioscience — Pelago Bioscience offers target engagement studies of drug candidate interactions with target proteins in cells and tissues.
Monesi is an invesment firm.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Phenaros Pharmaceuticals — Data-centric drug discovery with AI, Phenomics and Automation.
HJKK Didrikson operates as an investment firm.
Show more...Investment focus
- Industry: Biopharma, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- AAX Biotech — AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.
Phase2Phase Biopharma is a consulting company that offers CMC strategies, CRO, CMO, CDMO sourcing, CMC project management, and QA services.
Show more...Investment focus
- Industry: Biopharma, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- AAX Biotech — AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Inter IKEA Group's aim is to secure continuous improvement, development, expansion and a long life of the franchising operation.
Show more...Investment focus
- Industry: Software, Furniture, Health Care
- Stage:Seed, Corporate Round
- Geography: Germany, Sweden, Denmark
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- nyris — Our custom search engines make it easy for people to find products, spare parts, and components for industry and eCommerce
- NORNORM — High quality pre-loved office furniture, including office design, installation and flexibility to change. Own less, pay less, and change whenever.
- Seprify — Enabling sustainable products
Ackra Invest AB is a venture capital and private equity firm specializing in late venture, growth capital and turnaround investments. The firm does not have a sector preference and seeks to invest in small and middle sized companies based in Norrland; the Northern region of Sweden. It does not provide loans or invest in seed or early venture. Thefirm takes minority stakes, between 10 percent and 49 percent and invests between SEK1 million ($0.13 million) and SEK8 million ($1.02 million). It invests in equity or convertible loans and can perform co-investments. The firm seeks to exit its investments within seven years. Ackra Invest AB was founded in 2005 and is based in Skellefteå, Sweden.
Show more...Investment focus
- Industry: Manufacturing, Mining, Chemical
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Xore — Xore AB has develops and sells analyzers to enrichment plants in the mining industry.Xore is one of the world’s leading suppliers of on-stream analyzers and related services to the mining industry. Xore is the natural first choice when investing in equipment for on-stream analysis of pulp and liquids. Our product brand is Boxray™. Xore is agenuine Swedish engineering technology company based in Skellefteå in northern Sweden.
- Protab AB — Protab specializes in machining, turning and milling and manufactures details for the hydraulic and forest industry. Another important part of the business is system delivery, where the company also assembles the details that were manufactured.Protab manufactures components primarily for the hydraulics and forestry industries. System deliveries,where the company assembles manufactured components, form another important part of the operation. We also do value flow analyses to improve the efficiency of our customers' businesses. How can we make things better for you?
- Fortlax AB — Fortlax is Northern Sweden's data center with three world-class facilities just outside Piteå. We help companies grow using smart IT and cloud services. We store data in highest-class facilities at a location where risk analysis shows extremely low risk of natural disasters. In addition, we operate all our facilities with 100% green energy anduse natural cooling for large parts of the year. Fortlax AB has over the past fiscal year more than tripled its revenue and shows profit.
CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Seed, Series B
- Geography: Sweden, Denmark, Germany
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- GLX Analytix — GLX Analytix is a biomedical company that develops a new technology to identify a biomarker. The company was founded in 2019 and is based in Copenhagen, Denmark.
- Swiftly — World's first AI that applies for jobs. Say goodbye to creating CV's, searching and applying for jobs. Let Swiftly do it for you! Welcome to the new age.
- Hugel Control — HUGEL, Inc. strives to be a global company that continuously creates innovative products, promotes universal health, and improves the quality of life through state-of-the-art technology and creativity.
Leksell Social Ventures is the first professional impact investing company in Sweden. LSV seeks to evolve the practice of philanthropy through establishing social impact investing at an institutional scale in Sweden, building on inspiration from the UK and US. We are a non-profit, private investment company incorporated in Sweden. LSVfinances scalable, economically sustainable, well governed initiatives with evidence based and measurable social impact. LSV invests up to 1 mUSD through equity, loans, guarantees or grants. LSV is currently focusing on integration, mental ill health and tech for good initiatives Founded by life-science billionaire Laurent Leksell (Elekta AB) and Family LSV is run by CEO, Hugo Mörse and team.
Show more...Investment focus
- Industry: Health Care, Apps, Fitness
- Stage:Seed, Series B
- Geography: Sweden, United States
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Epigenica — Epigenica focuses on advancing epigenomics through its EpiFinder™ platform, a multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks. The company offers R&D services for the development of therapeutic molecules and diagnostic methods using epigenetics. Epigenica aims to improve scientists' ability to capture andextract insights from the epigenome, contributing to precision medicine and the discovery of new biomarkers.
- Meru Health — Meru Health is an online mental health provider that helps people improve their mental health long-term by treating depression, anxiety, and burnout.
- Health Integrator — Health Integrator is a digital marketplace for access to health services. The Health Integrator health platform provides easy access to a large number of activities and health services gathered in one place.
Almi Invest GreenTech is a venture capital company and an active start-up investor.
Show more...Investment focus
- Industry: Waste Management, Energy, Manufacturing
- Stage:Seed, Series A
- Geography: Sweden
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Zparq — Zparq designs and manufactures marine electric propulsion products.
- Modvion — Modvion is a Swedish/ American Engineering and Industrial Design company developing modular designs in renewable engineered wood product materials to simplify and improve construction logistics.Their current area of focus is in wind tower technology. Modvion´s patented module technology enables significantly decreased cost, efficienttransportation and streamlined installation of towers exceeding 120 m. Ultimately, this results in increased cost efficiency in the harvesting of wind resources.
- EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
Nxt2b is a venture capital company focused on investments in healthcare, pharmaceuticals companies, and medical devices.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Health Diagnostics
- Stage:Series A
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
KTH Holding is a state-owned limited company managed by KTH's University Board. It invests in promising startup companies that are based on research or teaching at KTH, with the aim of supporting commercialization and making it easier for new science to benefit society.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 21
- Lead/follow: no public data
Portfolio highlights
- Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.
- porkchop — In-space logistics for SmallSats in Low Earth Orbit and beyond.
- Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more...Investment focus
- Industry: Biotechnology, Life Science, Water
- Stage:Seed, Series A
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 26
- Lead/follow: no public data
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
- Happy Plant Protein — Revolutionize plant protein production with Happy Plant Protein's innovative technology, transforming local ingredients into high-quality, sustainable solutions for the food industry.
Knutsson Holdings AB is an family owned private equity firm.
Show more...Investment focus
- Industry: Gaming, Billing, Parking
- Stage:Series C
- Geography: Sweden, Germany
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Drifter — Drifter stays abreast of the latest technological trends in offering practical solutions for the parking and EV charging ecosystem.
- Unicorn Workspaces — Unicorn offers work solutions for teams of all sizes with flexible terms and independent of high market rental prices. It is a fast-growing shared office provider, with 21 workspaces in Berlin, Potsdam, Cologne, Munich, Hamburg, and LisbonTheir vision of “Workspace as a Service” is reflected in their all-inclusive offer, and support fromcommunity baristas. They combine their coffee expertise and community manager knowledge to provide seamless work experience. With their friendly attitude and eagerness to help, members and visitors will receive good advice and assistance.Each of their workspaces is equipped with a modern café, where they offer organic direct trade coffee and hot beverages for all of their members and guests. They also offer a small selection of cold drinks, salads, and desserts. The café functions as a central meeting point for their community.
- Resolution Games — Resolution Games is a Stockholm based studio focused on creating virtual reality (VR) and augmented reality (AR) immersive experiences for all.
Kale United offers a portfolio of over 75+ plant-based game changers
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Sweden, United Kingdom, Canada
Investor stats
- Total investments: 26
- Round size: Seed $360k–$2.5M; Pre-Seed $100k–$2M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
- Hooked Foods — Hooked Foods is working on a plant-based tuna substitute. By serving delicious plant-based seafood for everyone to enjoy, the company is leading the transition to a healthier seafood ecosystem. The company was established in 2019 and is headquartered in Sweden.
- Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
Biotechnology VC funding in Sweden at a glance
Stats across 343 deals from 300 investors.
Access all 300 VC funds in Sweden Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology VC Funds in Sweden investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 300 VC funds investing in Sweden Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!